Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.560
+0.020 (0.79%)
At close: Apr 28, 2026, 4:00 PM EDT
2.570
+0.010 (0.39%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
Moleculin Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 14 | 10 | 5 | 29 | 30 | 53 | |
| Market Cap Growth | 33.93% | 99.72% | -82.21% | -5.48% | -42.91% | 5.47% | |
| Enterprise Value | 5 | 4 | -4 | 5 | -20 | -22 | |
| Last Close Price | 2.56 | 3.31 | 42.50 | 321.90 | 397.50 | 697.50 | |
| PB Ratio | 0.55 | 0.68 | 0.46 | 1.10 | 0.58 | 0.67 | |
| P/TBV Ratio | 3.54 | 2.64 | 85.05 | 1.92 | 0.74 | 0.78 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.04 | 0.02 | 0.01 | 0.00 | |
| Net Debt / Equity Ratio | -0.57 | -0.57 | -0.34 | -0.88 | -0.82 | -0.90 | |
| Net Debt / EBITDA Ratio | 0.34 | 0.34 | 0.14 | 0.78 | 1.40 | 3.10 | |
| Net Debt / FCF Ratio | 0.38 | 0.38 | 0.16 | 0.97 | 1.54 | 3.73 | |
| Quick Ratio | 1.30 | 1.30 | 0.80 | 3.47 | 8.96 | 19.59 | |
| Current Ratio | 1.41 | 1.41 | 0.97 | 3.86 | 9.46 | 20.02 | |
| Return on Equity (ROE) | -256.05% | -256.05% | -139.74% | -76.07% | -44.25% | -32.86% | |
| Return on Assets (ROA) | -80.35% | -80.35% | -60.39% | -38.73% | -27.07% | -25.38% | |
| Return on Capital Employed (ROCE) | -164.40% | -164.40% | -230.30% | -94.40% | -58.20% | -28.50% | |
| Earnings Yield | -246.42% | -329.27% | -510.43% | -103.79% | -95.65% | -29.90% | |
| FCF Yield | -166.42% | -223.06% | -467.84% | -82.69% | -91.30% | -35.69% | |
| Buyback Yield / Dilution | -760.13% | -760.13% | -74.28% | -3.60% | -6.43% | -172.97% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.